Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

Product › Details

venture capital

	Next higher product group	private equity

Record changed: 2020-08-01

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for venture capital

[1] Enthera S.r.l.. (7/28/20). "Press Release: Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease". Milan....
[2] Tubulis GmbH. (7/21/20). "Press Release: Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates". Munich....
[3] Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen....
[4] Citryll B.V.. (7/2/20). "Press Release: Citryll Completes € 18.5 M Fundraise to Develop CIT-013, an Antibody Targeting Neutrophil Extracellular Traps". Oss....
[5] Enterome S.A.. (6/25/20). "Press Release: Enterome Completes €46.3 Million ($52.6 Million) Financing to Progress the Clinical Development of Its Therapeutic Pipeline". Paris & Cambridge, MA....
[6] eTheRNA Immunotherapeutics N.V.. (6/16/20). "Press Release: eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept". Niel....
[7] Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona....
[8] DiogenX. (6/16/20). "Press Release: DiogenX Raises €4.5M in Seed Financing from Advent France Biotechnology, Boehringer Ingelheim Venture Fund and JDRF T1D Fund". Marseille....
[9] Epsilen Bio S.r.l.. (6/15/20). "Press Release: Epsilen Bio Appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board. Company Announces Strategic Collaboration with SR-Tiget". Milan....
[10] Egle Therapeutics S.A.S.. (6/11/20). "Press Release: Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies". Pa...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top